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Abstract
Background: Although biocides at low concentrations have been used to control pests, they can be more harmful than
industrial chemicals as humans are directly and frequently exposed to such biocides. Benzalkonium chloride (BAC or BKC)
is a non-toxic substance used to control pests. Recently, BAC has been increasingly used as a component in humidifier
disinfectants in Korea, raising a serious health concern. Moreover, it poses significant health hazards to workers handling
the chemical because of direct exposure. In the present study, we aimed to evaluate the respiratory toxicity of BAC due
to its inhalation at exposure concentrations of 0.8 (T1 group), 4 (T2 group) and 20 (T3 group) mg/m3.
Results: In our previous study on the acute inhalational toxicity of BAC, bleeding from the nasal cavity was observed in all
the rats after exposure to 50mg/m3 BAC. Therefore, in this study, 20mg/m3 was set as the highest exposure
concentration, followed by 4 and 0.8mg/m3 as the medium and low concentrations for 6 h/day and 14 days, respectively.
After exposure, recovery periods of 2 and 4weeks were provided. Additionally, alveolar lavage fluid was analyzed in males
of the BAC-exposed groups at the end of exposure and 2weeks after exposure to evaluate oxidative damage.
In the T3 group exposed to BAC, deep breathing, hoarseness, and nasal discharge were observed along with a decline in
feed intake and body weight, and nasal discharge was also observed in the T1 and T2 groups. ROS/RNS, IL-1β, IL-6, and
MIP-2 levels decreased in a concentration-dependent manner in the bronchoalveolar lavage fluid. Histopathological
examination showed cellular changes in the nasal cavity and the lungs of the TI, T2, and T3 groups.
Conclusions: As a result, it was confirmed that the target organs in the respiratory system were the nasal cavity and the
lungs. The adverse effects were evaluated as reversible responses to oxidative damage. Furthermore, the no observed
adverse effect level was found to be less than 0.8mg/m3 and the lowest benchmark dose was 0.0031mg/m3.
Accordingly, the derived no-effect level of BAC was calculated as 0.000062mg/m3.
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Introduction
Biocides are non-agricultural pesticides used to control,
eliminate, inhibit, detoxify, or prevent harmful organisms
in ways other than mere physical and mechanical ac-
tions. They include active materials such as microorgan-
isms and substances that affect harmful organisms. A
product containing one or more of these active sub-
stances is called a biocidal product.
Currently, biocides are used extensively. In 2011, the
biocides caused several social problems in Korea because
of unexplained lung disease in pregnant women and in-
fants due to exposure to humidifier disinfectants. Fur-
thermore, these biocides are predicted to cause more
severe lung diseases among workers handling such sub-
stances than the general public due to direct and longer
exposure to biocides at a high concentration in the work
environment. However, currently, there is a lack of re-
search in this regard.
Benzalkonium chloride (BAC) was classed as a Cat-
egory III antiseptic active ingredient by the US FDA
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because of a lack of adequate safety data for its use as
both a health care antiseptic and consumer antiseptic
product [1]. BAC is a mixture of alkylbenzyl dimethy-
lammonium chlorides of various even-numbered alkyl
chain lengths (C8-C18) [2] and it is commonly used as
disinfectants in food, industrial and domestic areas [3].
The greatest biocide activity is associated with the C12-
C14 derivatives, which are the main components of the
mixture [2]. In general, the n-C12 homolog is most effect-
ive against yeast and fungi, and the n-C14 homolog
against gram-positive bacteria [4]. The mode of action of
quaternary ammonium compounds appears to be associ-
ated with their effect on the cytoplasmic membrane,
which controls cell permeability [3]. Furthermore, BAC
has also been used as an active ingredient (amount con-
tained in product: 0.045%, w/v) in humidifier disinfectants.
It is mainly used by diluting with water in an ultrasonic-
type humidifier, and therefore, it can be inhaled in the
form of aerosol generated into the atmosphere. Therefore,
BAC is suspected as a cause of the social disaster related
to humidifier disinfectant in Korea.
BAC is an active ingredient in several consumer prod-
ucts, including pharmaceutical products such as eye, ear,
and nasal drops or sprays, as a preservative; personal
care products such as hand sanitizers, wet wipes, sham-
poos, deodorants, and cosmetics; skin antiseptics, such
as Bactine and Dettol; throat lozenges [5] and mouth-
washes, as a biocide; spermicidal creams; over-the-
counter single-application treatments for herpes, cold-
sores, and fever blisters, such as RELEEV and Viroxyn;
burn and ulcer treatments; spray disinfectants for hard
surface sanitization; cleaners for floor and hard surfaces
as a disinfectant, such as Lysol; algaecides for clearing
algae, moss, and lichens from paths, roof tiles, swimming
pools, and masonry. BAC is also used in several non-
consumer processes and products; for example, as an ac-
tive ingredient in surgical disinfection. A comprehensive
list of uses includes industrial applications [6]. Benzalko-
nium chloride is a frequently used preservative in eye
drops; typical concentrations range from 0.004 to 0.01%.
Higher concentrations can be caustic [7] and can cause
irreversible damage to the corneal endothelium [8]. Oc-
cupational exposure to BAC has been linked to the de-
velopment of asthma [9]. Furthermore, BAC has been
commonly used as a pharmaceutical preservative and
antimicrobial since the 1940s. Therefore, there is a need
for studies to evaluate the effects of occupational expos-
ure to BAC in the form of aerosols, considering the as-
sociated health risks.
Benzalkonium chloride (CAS Registry Number
8001-54-5) was considered for this study because it
complies with the following five criteria for selecting
substances for occupational exposure assessment of
biocides [10].
(1) The products containing BAC have a high
frequency of use and BAC is identified as hazardous
by the Korea Institute of Disease Control.
(2) The substance is included in the designated
substances of EE Directive 98/8/EC Annexes 1 and
1A, and is distributed in Korea.
(3) The substance has been used frequently in
traditional workplaces and whose health risks have
been reported, but has poor or no exposure
assessment data.
(4) Data on the distribution quantity or import volume
is officially announced in the domestic distribution
quantity statistics data.
(5) Substance that is included in the above four items
and is capable of causing health hazards due to
occupational exposure in the form of an aerosol.
Although several previous studies on the toxicity of
BAC have been conducted individually, there is a lack of
toxicity studies on systemic inhalation exposure in ac-
cordance with the OECD GLP (Good Laboratory Prac-
tice) Test Guidelines. Therefore, in this study, we
evaluated the toxicity of respiratory exposure to BAC in
rats using a whole body chamber system and mist-
generating system. The rats were repeatedly exposed to
aerosols for 2 weeks to assess the toxic response induced
by BAC, and the recovery period of 2 and 4 weeks was
included to evaluate the reversibility of the induced toxic
response and to compare and analyze related cytokines.
Results
Concentration and particle size distribution of BAC in the
whole-body exposure chamber
The mean concentration of BAC in the whole-body ex-
posure chambers of the T1(0.8mg/m3), T2(4mg/m3) and
T3(20mg/m3) groups during the exposure period was
0.84 ± 0.09, 4.01 ± 0.12, and 19.57 ± 0.97mg/m3, respect-
ively, the MMAD of the aerosols was 1.614, 1.090, and
1.215 μm, respectively, and the GSD was 2.00, 1.86, and
1.51, respectively. The MMAD and GSD were confirmed
to be within the range recommended by the Organization
for Economic Cooperation and Development (OECD,
2018). The size distribution of BAC aerosol particles is
shown in Fig. 1. The T95, which is the time to reach 95%
concentration of 0.8, 4, and 20mg/m3 BAC in the cham-
ber, was 7.1, 5.7, and 3.4 min, respectively, as measured
using a Portable Aerosol Spectrometer (Model 11-A,
GRIMM Aerosol Technik GmbH & Co. KG, Germany).
Clinical signs, body weight, and feed intake
None of the rats in the test groups died during the ex-
posure period. In the T1 group, nasal discharge was ob-
served in two female rats. In the T2 group, nasal
discharge was observed in 2 male and 3 female rats. In
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the T3 group, deep breathing was observed in 1 male
rat, rales in 5 male rats, and nasal discharges in 5 female
and 5 male rats. Among the general signs observed dur-
ing the exposure period, soiled perineal region, rales,
and discharge were continuously observed during the 2-
week recovery period.
With respect to the body weight, the T3 and T2
groups of the male and female rats showed a statisti-
cally significant decrease compared with that of the
control group rats during the exposure period, but no
statistically significant weight loss was observed in the
T1 group of male and female rats. In the recovery
groups of male rats, statistically significant differences
were observed only in the T3 group rats during the
recovery period (Fig. 2).
During the exposure period, a statistically signifi-
cant decrease in feed intake was observed in the
male rats of the T2 and T3 groups, and in the fe-
male rats of the T3 group compared with that in the
control group rats. No statistically significant
changes in feed intake were observed in the T1
group compared with that in the control group. Dur-
ing the recovery period, a statistically significant re-
duction in feed intake was observed only at 1 week
of recovery in the T3 group, and there was no de-
crease in feed intake thereafter (Fig. 3).
Fig. 1 Particle size distributions of BAC in the chambers. 0.8 mg/m3(a), 4.0 mg/m3(b), 20 mg/m3 (c)
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Hematology and blood biochemistry
Among the male rats in the main groups, the red blood
cell (RBC) count, hematocrit (HCT) level, hemoglobin
(Hb), mean corpuscular hemoglobin concentration
(MCHC), activated partial thromboplastin time (APTT),
and prothrombin time (PT) showed a statistically signifi-
cant increase compared with those of the control and
the mean corpuscular volume (MCV), platelet (PLT)
count, absolute count of lymphocyte, absolute and rela-
tive counts of reticulocytes showed a statistically signifi-
cant decrease in the T3 group. The T2 group showed a
statistically significant increase in the RBC count, HCT
and Hb level, absolute and relative counts of eosinophils
and PT, and a statistically significant decrease in the
PLT level compared with those of the control group. In
the T1 group, a statistically significant increase was ob-
served in the Hb level compared with that in the control.
In female rats of the main groups, the results of
hematological analysis showed a statistically significant
decrease in the WBC count, absolute counts of lympho-
cyte and monocyte, relative count of reticulocytes com-
pared with those in the control, and a statistically
significant increase in the APTT and PT in the T3
group. A statistically significant increase in the PT was
observed only in the T2 test group. The remaining pa-
rameters showed no statistically significant change
(Table 1). After 2 weeks of recovery period, the MCV,
absolute and relative counts of reticulocytes, and PLT of
the male recovery T3 group showed a statistically signifi-
cant increase compared with those of the control. The
male recovery T2 group showed a statistically significant
increase in the absolute and relative counts of reticulo-
cytes and PLT compared with those of the control. The
remaining parameters showed no statistically significant
change. After 4 weeks of recovery period, the MCV,
MCH, and PT of the male recovery T3 group showed a
statistically significant increase compared with those of
the control (Table 2), but no statistically significant
change was observed in the other parameters (Add-
itional file 1: Tables S1 and S2).
In male rats of the main groups, the results of the
blood biochemical analysis showed a statistically signifi-
cant decrease compare to control in the ALP and CK ac-
tivities, and TG level and a statistically significant
increase in the ALT activity in the T3 group rats. In the
T2 group, a statistically significant decrease in the ALP
Fig. 2 Changes of body weights in the rats exposed to BAC. Males (a) and Females (b) of the main groups, Males (c) of the recovery groups.
Significantly different from control by Dunnett test: *p < 0.05, **p < 0.01. Significantly different from control by Dunn Rank Sum test:
*p < 0.05, **p < 0.001
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activity was observed, but the remaining parameters
showed no statistically significant change compare to
control. In female rats of the main groups, the Na level
in the T2 and T3 group rats and K level in the T2 group
rats showed a statistically significant increase compared
with those in the control group. The remaining parame-
ters showed no statistically significant change (Table 1).
After 2weeks of recovery period, a statistically significant in-
crease was observed in the ALP activity in the T3 and T2
male recovery groups. After 4weeks of recovery period, a
statistically significant increase was observed in the Na and
Cl levels and ALP activity in the T3 group rats and a statisti-
cally significant increase in the Na level in the T2 group rats
compare with those in the control (Table 2), but the
remaining parameters did not show any statistically signifi-
cant changes (Additional file 1: Tables S3 and Table S4).
Organ weights
In the male rats of the T3 group, the absolute weight of
brain, heart, lung, liver, spleen and kidney and the rela-
tive weight of liver and spleen were statistically signifi-
cant decreased, and the relative weight of brain, heart,
lung and kidney was statistically significant increased
compared with those of the control group. In the male
rats of the T2 group, the absolute weight of liver, spleen
and kidney and the relative weight of liver and spleen
were statistically significant decreased, and the relative
weight of lung was statistically significant increased
compared with those of the control group. In the female
rats of the T3 group, the absolute weight of heart, liver,
spleen and kidney and the relative weight of spleen were
statistically significant decreased, and the relative weight
of brain, heart and lung was statistically significant in-
creased compared with those of the control group. In
the female rats of the T2 group, the absolute weight of
liver and spleen was statistically significant decreased
compared with those of the control group (Table 3).
In the male rats of the recovery group, the relative
weight of the brain, heart, and lung of the T3 group was
statistically significant increased, and the absolute weight
of the liver was statistically significant decreased com-
pared with those of the control group after 2 weeks of
recovery period. After 4 weeks of recovery period, the
relative weight of the brain in the T3 and T2 groups was
statistically significant increased compared with that in
the control group (Table 4).
Gross and histopathological findings
In the male rats, black focus of the lungs and a decrease
in the size of the liver, spleen, thymus, testis, epididymis,
seminal vesicle, and prostate were observed in the T3
group. In the female rats, a decrease in the size of
Fig. 3 Changes of feed intake in the rats exposed to BAC. Males (a) and Females (b) in the main groups, Males (c) in the recovery groups
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thymus, uterus, and vagina was observed in the T3
group and a decrease in the size of the uterus and vagina
was observed in the T2 group. After the recovery period,
these necropsy findings in BAC exposed male rats were
not observed (data not shown).
Histological examinations were conducted to dis-
cern the morphological differences between the end
of the BAC exposure period and the end of the re-
covery period. Representative micrographs of the
lung and nasal tissues of the control and test groups
are shown in Figs. 4–5 and Tables 5–6 [11]. The
rats from the control group showed a normal
parenchyma at all time points. However, at the end
of exposure, degeneration and regeneration of ter-
minal bronchiolar epithelium, smooth muscle hyper-
trophy of bronchioloalveolar junction, cell debris in
the alveolar lumens was observed in the male T2
and T3 groups and female T3 group. Hypertrophy
and hyperplasia of mucous cells in the bronchi or
bronchiole were observed in both males and females.
In the nasal cavity, ulceration with suppurative in-
flammation, squamous metaplasia, and erosion with
necrosis were observed in the respiratory epithelium
and transitional epithelium of the male and female





0 0.8 4 20 0 0.8 4 20
Hematology
WBC (× 103/μL) 4.17 ± 0.73 4.56 ± 0.46 3.47 ± 0.72 3.07 ± 0.84 4.42 ± 0.59 4.09 ± 0.54 3.55 ± 0.60 2.50 ± 0.39b
RBC (×106/μL) 8.40 ± 0.29 8.68 ± 0.16 8.97 ± 0.13b 9.56 ± 0.19b 9.04 ± 0.21 8.82 ± 0.10 9.21 ± 0.15 9.54 ± 0.37
HCT (%) 43.52 ± 1.27 44.56 ± 1.17 45.42 ± 0.69a 48.12 ± 1.16b 45.28 ± 0.59 44.48 ± 0.61 46.12 ± 0.76 47.58 ± 2.35
Hb (g/dL) 14.50 ± 0.26 14.96 ± 0.21a 15.42 ± 0.30b 16.44 ± 0.34b 15.60 ± 0.24 15.32 ± 0.42 15.86 ± 0.23 16.40 ± 0.67
MCV (fL) 51.84 ± 1.06 51.30 ± 0.57 50.62 ± 0.59 50.32 ± 0.37c 50.14 ± 0.67 50.40 ± 0.46 50.06 ± 0.39 49.88 ± 0.51
MCH (g/dL) 17.28 ± 0.37 17.24 ± 0.15 17.20 ± 0.37 17.22 ± 0.16 17.28 ± 0.28 17.38 ± 0.35 17.20 ± 0.10 17.20 ± 0.07
MCHC (g/dL) 33.28 ± 0.52 33.62 ± 0.50 33.96 ± 0.49 34.16 ± 0.37a 34.46 ± 0.25 34.44 ± 0.72 34.36 ± 0.17 34.46 ± 0.39
RETA (× 109/L) 260.70 ± 41.33 241.48 ± 22.83 190.72 ± 17.52 30.48 ± 2.94d 186.50 ±
40.82
162.16 ± 28.66 139.66 ± 14.54 137.66 ±
15.18
RET (%) 3.12 ± 0.58 2.79 ± 0.29 2.12 ± 0.20 0.32 ± 0.03d 2.07 ± 0.50 1.84 ± 0.33 1.52 ± 0.18 1.44 ± 0.12c
PLT (×103/μL) 928 ± 39 892 ± 23 823 ± 43b 510 ± 39b 840 ± 49 806 ± 47 844 ± 78 842 ± 73
LYMA (×103/μL) 3.22 ± 0.51 3.58 ± 0.41 2.45 ± 0.58 2.23 ± 0.67a 3.35 ± 0.51 3.22 ± 0.58 2.68 ± 0.64 1.78 ± 0.19b
MONA (×103/μL) 0.08 ± 0.02 0.10 ± 0.01 0.07 ± 0.03 0.07 ± 0.04 0.13 ± 0.03 0.09 ± 0.01 0.09 ± 0.04 0.07 ± 0.02b
EOSA (×103/μL) 0.05 ± 0.01 0.07 ± 0.02 0.08 ± 0.02a 0.05 ± 0.02 0.06 ± 0.01 0.07 ± 0.03 0.07 ± 0.02 0.06 ± 0.01
EOS% (%) 1.20 ± 0.27 1.46 ± 0.26 2.34 ± 0.23a 1.80 ± 0.90 1.40 ± 0.25 1.78 ± 0.90 2.02 ± 0.31 2.38 ± 0.30
BAS%(%) 0.32 ± 0.05 0.26 ± 0.09 0.18 ± 0.08a 0.18 ± 0.08a 0.30 ± 0.14 0.32 ± 0.05 0.22 ± 0.08 0.26 ± 0.18
APTT (sec) 16.26 ± 0.67 17.10 ± 0.55 18.12 ± 0.66 21.08 ± 1.89d 17.44 ± 1.46 16.88 ± 0.51 17.78 ± 0.70 19.32 ± 0.92a
PT (sec) 11.00 ± 0.38 10.98 ± 0.61 12.04 ± 0.42a 12.78 ± 0.68b 11.18 ± 0.37 11.58 ± 0.30 12.64 ± 0.54b 13.70 ± 0.41b
Clinical chemistry
ALT (IU/L) 36.06 ± 3.04 37.28 ± 3.52 35.24 ± 2.64 47.22 ± 11.48a 30.14 ± 2.59 28.02 ± 3.39 32.34 ± 3.24 36.52 ± 5.64






592.44 ± 52.97 647.14 ± 21.79 639.04 ±
74.65
TG (mg/dL) 53.98 ± 20.09 49.26 ± 9.06 27.02 ± 6.12 17.92 ± 1.44b 16.76 ± 3.52 16.26 ± 5.62 12.88 ± 2.39 16.56 ± 2.96
















Cl (mmol/L) 94.62 ± 0.71 96.32 ± 3.05 95.56 ± 0.20 91.06 ± 2.88 97.62 ± 1.40 97.78 ± 0.61 99.04 ± 0.63 97.32 ± 1.15
K (mmol/L) 4.52 ± 0.22 4.62 ± 0.13 4.80 ± 0.19 4.64 ± 0.37 4.08 ± 0.16 4.06 ± 0.11 4.32 ± 0.15a 4.26 ± 0.13
Na (mmol/L) 134.70 ± 0.49 135.72 ± 2.96 134.98 ± 0.67 136.34 ± 1.176 134.58 ± 0.52 135.22 ± 0.61 136.80 ± 0.83b 138.10 ±
0.77b
The values are expressed as mean ± SD (n = 5 males and 5 females per group)
aDunnett Test Significant at the 0.05 level, bDunnett Test Significant at the 0.01 level
cDunn Rank Sum Test Significant at the 0.05 level, dDunn Rank Sum Test Significant at the 0.01 level
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T3 groups. Hypertrophy and hyperplasia of mucous
cells in the respiratory epithelium were observed in
both males and females, and metaplasia of mucous
cells in the transitional epithelium was observed in
the male and female T1 and T2 groups. In addition,
atrophy of olfactory epithelium was observed in the
male and female T3 groups.
In the nasal cavity, after 2 weeks of recovery period,
hyperplasia of transitional epithelium in the T2 and T3
recovery groups, hypertrophy and hyperplasia of mucous
cells in respiratory epithelium in all the recovery groups,
metaplasia of mucous cells in transitional epithelium in
the T1 and T2 recovery groups, infiltration of sub-
mucosa in transitional and respiratory epithelium in the
T3 recovery group, and squamous metaplasia in transi-
tional epithelium in the T3 recovery group were ob-
served. After 4 weeks of recovery period, hyperplasia in
transitional epithelium, hypertrophy and hyperplasia of
mucous cells in respiratory epithelium, infiltration of
submucosa, and squamous metaplasia in transitional epi-
thelium were observed in the T3 recovery group.
Analysis of BALF
There was no statistically significant difference in the
total cell and differential cell counts between the BALF
obtained at the end of exposure period (14 days) and 4
weeks of recovery (42 days) (Fig. 6). We measured the
concentration of reactive oxygen species (ROS) and
Table 2 Hematologic and blood chemical parameters of recovery group male rats exposed to benzalkonium chloride
Recovery group
Recovery period 2 Weeks 4 Weeks
Concentration (mg/
m3)
0 0.8 4 20 0 0.8 4 20
Hematology
WBC (×103/μL) 4.65 ± 1.10 4.65 ± 0.50 4.48 ± 0.92 4.64 ± 0.71 4.70 ± 0.46 5.38 ± 0.69 4.45 ± 0.54 3.74 ± 1.15
RBC (×106/μL) 9.02 ± 0.31 8.98 ± 0.112 8.96 ± 0.27 8.95 ± 0.16 8.89 ± 0.10 9.00 ± 0.19 8.89 ± 0.16 8.77 ± 0.31
HCT (%) 43.68 ± 1.37 43.40 ± 0.68 43.66 ± 0.84 44.22 ± 0.93 42.16 ± 0.26 42.62 ± 0.66 42.52 ± 0.44 42.78 ± 1.71
Hb (g/dL) 14.84 ± 0.47 14.72 ± 0.30 14.72 ± 0.34 14.90 ± 0.29 14.28 ± 0.24 14.46 ± 0.22 14.38 ± 0.15 14.38 ± 0.50
MCV (fL) 48.42 ± 0.36 48.32 ± 0.36 48.80 ± 0.68 49.38 ± 0.21b 47.40 ± 0.39 47.32 ± 0.40 47.84 ± 0.54 48.74 ± 0.55b
MCH (g/dL) 16.4 ± 0.1 16.4 ± 0.2 16.4 ± 0.2 16.7 ± 0.1 16.00 ± 0.09 16.10 ± 0.11 16.10 ± 0.25 16.40 ± 0.07b
MCHC (g/dL) 33.91 ± 0.07 33.94 ± 0.25 33.70 ± 0.30 33.74 ± 0.30 33.92 ± 0.43 33.96 ± 0.13 33.78 ± 0.31 33.60 ± 0.27




270.34 ± 16.42 239.50 ± 18.57 280.40 ± 25.11 292.90 ± 20.89
RET (%) 2.78 ± 0.40 2.86 ± 0.05 3.67 ± 0.58b 3.58 ± 0.33a 3.04 ± 0.18 2.66 ± 0.25 3.15 ± 0.32 3.34 ± 0.18
PLT (×103/μL) 788.0 ± 37.29 816.4 ± 11.78 871.4 ± 32.55c 872.2 ± 21.35c 787 ± 20 773 ± 43 806 ± 36 789 ± 49
LYMA (×103/μL) 3.23 ± 0.87 3.37 ± 0.37 3.13 ± 0.84 3.29 ± 0.42 3.40 ± 0.44 3.89 ± 0.27 2.89 ± 0.72 2.58 ± 0.87
MONA (×103/μL) 0.12 ± 0.05 0.10 ± 0.37 0.11 ± 0.03 0.13 ± 0.05 0.11 ± 0.03 0.12 ± 0.02 0.12 ± 0.02 0.08 ± 0.01
EOSA (×103/μL) 0.07 ± 0.01 0.07 ± 0.01 0.06 ± 0.01 0.07 ± 0.02 0.07 ± 0.03 0.08 ± 0.02 0.06 ± 0.02 0.06 ± 0.01
EOS% (%) 1.44 ± 0.21 1.52 ± 0.26 1.28 ± 0.30 1.48 ± 0.16 1.48 ± 0.48 1.48 ± 0.31 1.42 ± 0.43 1.68 ± 0.31
APTT (sec) 19.48 ± 2.32 18.92 ± 0.66 19.12 ± 0.35 21.04 ± 3.60 16.54 ± 0.68 17.22 ± 0.42 16.70 ± 0.44 16.90 ± 0.57
APT (sec) 10.28 ± 0.16 10.72 ± 0.52 9.98 ± 0.11 10.24 ± 0.24 10.46 ± 0.35 10.68 ± 0.26 10.38 ± 0.42 11.42 ± 0.46b
Clinical chemistry
ALT (IU/L) 49.40 ± 23.18 39.28 ± 2.88 40.52 ± 1.10 42.12 ± 2.80 41.40 ± 1.05 43.18 ± 1.00 42.18 ± 1.25 45.02 ± 6.36




594.10 ± 24.24 579.14 ± 23.36 648.06 ± 40.10 680.92 ±
62.32a
TG (mg/dL) 74.30 ± 9.57 66.82 ± 12.77 74.64 ± 24.61 63.28 ± 9.17 104.52 ± 25.24 84.08 ± 27.14 94.68 ± 37.22 59.40 ± 18.83
















Cl (mmol/L) 102.48 ± 1.21 103.94 ± 0.85 104.10 ± 0.88 103.24 ± 1.44 102.24 ± 1.30 103.20 ± 1.39 103.96 ± 0.40 104.20 ± 0.91a
K (mmol/L) 4.56 ± 0.68 4.36 ± 0.53 4.34 ± 0.57 4.92 ± 1.06 4.40 ± 0.46 4.52 ± 0.80 5.04 ± 0.42 4.56 ± 0.80
Na (mmol/L) 143.74 ± 1.44 144.24 ± 0.81 144.92 ± 0.41 143.92 ± 1.43 143.40 ± 0.68 143.50 ± 0.62 144.34 ± 0.44a 144.64 ± 0.49b
The values are expressed as mean ± SD (n = 5 males per group)
aDunnett Test Significant at the 0.05 level, bDunnett Test Significant at the 0.01 level
cDunn Rank Sum Test Significant at the 0.01 level
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reactive nitrogen species (RNS), as an index of oxidative
damage, and cytokines (IL-1β, TNF-α, IL-4, IL-6, MIP-2,
and TGF-β) in the BALF. The concentrations of IL-1β,
IL-6 and MIP-2 showed a statistically significant de-
crease at the end of the exposure period, but these
changes were not observed in the 4-week recovery group
except IL-6 in the T3 group (Fig. 7). In addition, the
concentration of ROS/RNS showed a concentration-
dependent decrease, although not a statistically signifi-
cant change. However, the concentrations of TNF-α, IL-
4 and TGF-β did not show statistically significant
changes after exposure to the test substance.
Table 3 Absolute and relative organ weights of main group rats exposed to benzalkonium chloride
Main group
Sex Male Female
Concentration (mg/m3) 0 0.8 4 20 0 0.8 4 20
Absolute organ weight (g)
Brain 1.767 ± 0.017 1.758 ± 0.041 1.706 ± 0.039a 1.683 ± 0.030b 1.668 ± 0.020 1.659 ± 0.056 1.624 ± 0.097 1.630 ± 0.056
Heart 0.646 ± 0.026 0.603 ± 0.054 0.536 ± 0.022 0.467 ± 0.032## 0.474 ± 0.034 0.445 ± 0.010 0.435 ± 0.036 0.422 ± 0.022a
Lung 0.330 ± 0.031 0.350 ± 0.026 0.349 ± 0.016 0.309 ± 0.022 0.273 ± 0.050 0.286 ± 0.015 0.299 ± 0.016 0.329 ± 0.071
Liver 5.803 ± 0.257 5.282 ± 0.479 4.513 ± 0.476b 3.369 ± 0.237b 3.664 ± 0.300 3.493 ± 0.102 3.192 ± 0.274a 3.082 ± 0.194b
Spleen 0.457 ± 0.037 0.438 ± 0.034 0.330 ± 0.021b 0.214 ± 0.026b 0.329 ± 0.046 0.317 ± 0.023 0.274 ± 0.016a 0.220 ± 0.010b
Kidney 1.384 ± 0.074 1.319 ± 0.077 1.180 ± 0.082b 1.031 ± 0.068b 0.999 ± 0.068 0.978 ± 0.038 0.926 ± 0.051 0.895 ± 0.066a
Relative organ weight (%)
Brain 0.934 ± 0.049 0.978 ± 0.078 1.083 ± 0.107 1.383 ± 0.119b 1.274 ± 0.064 1.309 ± 0.073 1.359 ± 0.054 1.507 ± 0.073b
Heart 0.342 ± 0.021 0.333 ± 0.009 0.340 ± 0.024 0.382 ± 0.015b 0.362 ± 0.017 0.351 ± 0.011 0.364 ± 0.016 0.390 ± 0.020a
Lung 0.175 ± 0.022 0.194 ± 0.010 0.221 ± 0.016b 0.254 ± 0.020b 0.208 ± 0.033 0.226 ± 0.009 0.251 ± 0.031 0.304 ± 0.066b
Liver 3.064 ± 0.091 2.923 ± 0.110 2.841 ± 0.085b 2.757 ± 0.112b 2.791 ± 0.011 2.753 ± 0.077 2.667 ± 0.115 2.844 ± 0.084
Spleen 0.241 ± 0.023 0.242 ± 0.009 0.208 ± 0.009b 0.175 ± 0.014b 0.250 ± 0.025 0.250 ± 0.016 0.230 ± 0.021 0.204 ± 0.011b
Kidney 0.732 ± 0.054 0.732 ± 0.049 0.745 ± 0.024 0.843 ± 0.023b 0.761 ± 0.021 0.771 ± 0.042 0.775 ± 0.050 0.826 ± 0.048
The values are expressed as mean ± SD (n = 5 males and 5 females per group)
aDunnett Test Significant at the 0.05 level, bDunnett Test Significant at the 0.01 level
##Dunn Rank Sum Test Significant at the 0.01 level
Table 4 Absolute and relative organ weights of recovery group male rats exposed to benzalkonium chloride
Recovery group
Recovery period 2 Weeks 4 Weeks
Concentration (mg/m3) 0 0.8 4 20 0 0.8 4 20
Absolute organ weight (g)
Brain 1.751 ± 0.101 1.804 ± 0.053 1.796 ± 0.018 1.695 ± 0.081 1.831 ± 0.061 1.774 ± 0.095 1.815 ± 0.030 1.786 ± 0.100
Heart 0.702 ± 0.076 0.718 ± 0.030 0.700 ± 0.037 0.681 ± 0.032 0.771 ± 0.034 0.743 ± 0.037 0.736 ± 0.061 0.721 ± 0.086
Lung 0.387 ± 0.035 0.424 ± 0.023 0.394 ± 0.035 0.388 ± 0.021 0.430 ± 0.030 0.419 ± 0.030 0.438 ± 0.043 0.416 ± 0.012
Liver 6.765 ± 0.493 6.738 ± 0.403 6.512 ± 0.131 5.847 ± 0.140b 7.545 ± 0.576 7.225 ± 0.697 6.987 ± 0.605 6.785 ± 0.578
Spleen 0.517 ± 0.031 0.547 ± 0.027 0.534 ± 0.066 0.488 ± 0.024 0.621 ± 0.064 0.582 ± 0.039 0.575 ± 0.058 0.564 ± 0.036
Kidney 1.573 ± 0.101 1.566 ± 0.100 1.538 ± 0.086 1.424 ± 0.059 1.662 ± 0.122 1.625 ± 0.103 1.583 ± 0.067 1.557 ± 0.070
Relative organ weight (%)
Brain 0.772 ± 0.053 0.799 ± 0.030 0.826 ± 0.014 0.871 ± 0.059b 0.700 ± 0.031 0.707 ± 0.040 0.761 ± 0.021a 0.761 ± 0.021a
Heart 0.309 ± 0.025 0.318 ± 0.010 0.322 ± 0.016 0.349 ± 0.010b 0.295 ± 0.013 0.296 ± 0.014 0.307 ± 0.025 0.307 ± 0.025
Lung 0.171 ± 0.015 0.188 ± 0.016 0.181 ± 0.013 0.199 ± 0.015a 0.165 ± 0.019 0.167 ± 0.007 0.177 ± 0.006 0.177 ± 0.006
Liver 2.974 ± 0.082 2.981 ± 0.088 2.992 ± 0.045 3.002 ± 0.054 2.878 ± 0.041 2.870 ± 0.139 2.888 ± 0.126 2.889 ± 0.126
Spleen 0.228 ± 0.009 0.242 ± 0.010 0.245 ± 0.025 0.250 ± 0.008 0.237 ± 0.010 0.232 ± 0.009 0.238 ± 0.012 0.240 ± 0.008
Kidney 0.692 ± 0.018 0.693 ± 0.024 0.706 ± 0.030 0.732 ± 0.032 0.656 ± 0.019 0.647 ± 0.020 0.664 ± 0.017 0.664 ± 0.017
The values are expressed as mean ± SD (n = 5 males per group)
aDunnett Test Significant at the 0.05 level, bDunnett Test Significant at the 0.01 level
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Discussion
Benzalkonium chloride, a quaternary ammonium
compound, is a mixture of several n-
alkylbenzyldimethylammonium chlorides (n = 10–16)
with different alkyl groups [12]. It is a cationic sur-
factant used as a bactericide or preservative owing to
its inhibitory action against bacteria and fungi [13]. It
is known that the long alkyl group of BAC interferes
with the double-layered bacterial cell membrane, de-
stroys it, and leaks the cell contents, and thus inhibits
bacterial growth [14, 15]. Studies have reported the
side effects of BAC, such as skin irritation and
dermatitis due to exposure via inhalation [16–18].
Globally, BAC is commonly used as sterilizing and
preserving agents in household chemical products
such as spray-type antimicrobial agents, perfumes
[19], and deodorants. Some studies have reported re-
spiratory toxicity of BAC. Exposure to BAC induced
cytotoxicity and DNA damage in human bronchial
cell line (BEAS-2B) [20], and acute or repeated
Fig. 4 In the lungs of male rats exposed to BAC, black arrows indicate hypertrophy and hyperplasia; red arrows indicate degeneration and
regeneration; red triangle indicates smooth muscle hypertrophy
Fig. 5 In the nasal tissues of male rats exposed to BAC, black arrows indicate hypertrophy and hyperplasia; black triangles indicate metaplasia; red
arrows indicate squamous metaplasia; blue arrows indicate erosion with necrosis; asterisk indicates ulceration with suppurative inflammation;
green filled triangles indicate hyperplasia
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Table 5 Histopathological assessment of the lung and nasal cavity tissues
Main group
Sex Male Female
Concentration (mg/m3) 0 0.8 4 20 0 0.8 4 20
Lung
Number of animals 5 5 5 5 5 5 5 5
Degeneration/regeneration, terminal bronchiolar epithelium (0) (0) (2) (5) (0) (0) (0) (3)
Minimal 0 0 2 3 0 0 0 3
Mild 0 0 0 2 0 0 0 0




0 0 0 0.60 ±
0.55
Hypertrophy/hyperplasia, mucous cells, bronchi/bronchiole (0) (5) (5) (3) (0) (3) (5) (4)
Minimal 0 0 0 2 0 3 1 3
Mild 0 5 3 1 0 0 2 1
Moderate 0 0 2 0 0 0 2 0












Smooth muscle hypertrophy, bronchioloalveolar junction (0) (0) (3) (5) (0) (0) (0) (3)
Minimal 0 0 3 5 0 0 0 3




0 0 0 0.60 ±
0.55
Infiltration, eosinophil, perivascular (0) (1) (3) (1) (0) (0) (0) (2)
Minimal 0 1 3 1 0 0 0 2






0 0 0 0.40 ±
0.55
Cellular debris, alveolar lumen (0) (0) (3) (2) (0) (0) (0) (1)
Minimal 0 0 3 2 0 0 0 1




0 0 0 0.20 ±
0.45
Nasal cavity
Number of animals 5 5 5 5 5 5 5 5
Ulceration with suppurative inflammation, respiratory
epithelium
(0) (0) (0) (1) (0) (0) (0) (2)
Mild 0 0 0 1 0 0 0 1
Marked 0 0 0 0 0 0 0 1
Mean ± SD 0 0 0 0.40 ±
0.89
0 0 0 1.20 ±
1.79
Ulceration with suppurative inflammation, transitional
epithelium
(0) (0) (0) (3) (0) (0) (0) (0)
Mild 0 0 0 1 0 0 0 0
Moderate 0 0 0 0 0 0 0 1
Marked 0 0 0 2 0 0 0 0
Mean ± SD 0 0 0 2.00 ±
2.00
0 0 0 0.60 ±
1.34
Squamous metaplasia, respiratory epithelium (0) (0) (0) (5) (0) (0) (0) (5)
Minimal 0 0 0 0 0 0 0 1
Mild 0 0 0 2 0 0 0 2
Moderate 0 0 0 3 0 0 0 1
Marked 0 0 0 0 0 0 0 1
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inhalation of BAC induced lung irritation, inflamma-
tion, and alveolar damage [3, 21, 22]. In addition, or-
ally or intravenously administered BAC has been reported
to accumulate predominantly in the lungs of rats, leading
to pulmonary edema and pneumonia [23, 24]. Therefore,
the lungs are considered to be the main target organ of
BAC. Recently, BAC is suspected to be one of the causa-
tive substances of toxicity involving humidifier fungicides
Table 5 Histopathological assessment of the lung and nasal cavity tissues (Continued)
Main group
Sex Male Female
Mean ± SD 0 0 0 2.20 ±
1.10
0 0 0 2.40 ±
1.14
Squamous metaplasia, transitional epithelium (0) (0) (0) (5) (0) (0) (0) (1)
Minimal 0 0 0 0 0 0 0 4
Mild 0 0 0 4 0 0 0 1
Moderate 0 0 0 1 0 0 0 0
Mean ± SD 0 0 0 1.40 ±
0.89
0 0 0 1.20 ±
0.45
Erosion with necrosis, respiratory epithelium (0) (0) (0) (5) (0) (0) (0) (3)
Minimal 0 0 0 3 0 0 0 0
Mild 0 0 0 1 0 0 0 1
Moderate 0 0 0 1 0 0 0 1
Marked 0 0 0 0 0 0 0 1
Mean ± SD 0 0 0 1.60 ±
0.89
0 0 0 1.80 ±
1.79
Erosion with necrosis, transitional epithelium (0) (0) (0) (5) (0) (0) (0) (4)
Minimal 0 0 0 2 0 0 0 1
Mild 0 0 0 1 0 0 0 0
Moderate 0 0 0 1 0 0 0 1
Marked 0 0 0 1 0 0 0 2
Mean ± SD 0 0 0 2.20 ±
1.30
0 0 0 2.40 ±
1.82
Hypertrophy/hyperplasia, mucous cells, respiratory epithelium (0) (5) (5) (5) (0) (5) (5) (5)
Minimal 0 0 1 1 0 0 1 0
Mild 0 3 0 2 0 0 2 5
Moderate 0 2 4 2 0 4 2 0
Marked 0 0 0 0 0 1 0 0












Metaplasia, mucous cells, transitional epithelium (0) (5) (5) (0) (0) (5) (5) (0)
Minimal 0 0 4 0 0 0 1 0
Mild 0 1 1 0 0 1 4 0
Moderate 0 4 0 0 0 4 0 0









Atrophy, olfactory epithelium (0) (0) (0) (1) (0) (0) (0) (2)
Mild 0 0 0 1 0 0 0 1
Moderate 0 0 0 0 0 0 0 1
Mean ± SD 0 0 0 0.20 ±
0.45
0 0 0 0.60 ±
0.89
0: unremarkable = no presence of histopathologic lesion; 1: minimal = lesions involving< 10% of the tissue of each organ; 2: mild = lesions involving< 10–30% of
the tissue of each organ; 3: moderate = lesions involving< 30–50% of the tissue of each organ; 4: marked = lesions involving< 50–70% of the tissue of each organ;
5: severe = lesions involving> 70% of the tissue of each organ
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in Korea. In the present study, the inhalation toxicity test
was performed to investigate the toxicity of BAC
inhalation.
To evaluate the toxic effects of repeated exposure
to BAC, F344 rats were exposed to 0.8, 4, and 20
mg/m3 BAC, 6 h/day for 14 days. We also set up a
recovery period of two and 4 weeks to assess the
reversibility of these effects. The mean concentra-
tion of BAC in the whole-body exposure chamber
measured during the exposure period was in ac-
cordance with that used in the inhalation test for
aerosols because the error from the target concen-
tration was ≤20%. The MMAD and GSD of the
aerosols measured during the exposure period also
met the aerosol inhalation test requirements in the
OECD TG412 [25].
During the exposure period, nasal discharge, rale, and deep
respiration were observed in the T3 group, and nasal dis-
charge observed in the T1 and T2 groups. These clinical
signs are thought to be an emergency airway response
caused by the irritation of BAC. The emergency airway
defense response consists of glottal closure, airway constric-
tion, pulmonary vessel dilation, cough, and copious gland se-
cretion. The emergency airway defense response is centrally
mediated and depends on intact vagal connections to the
lungs [26]. During the exposure period, a significant weight
loss was observed in males in the T2 and T3 groups and fe-
males in the T3 test group, and more weight loss was ob-
served in males than in females, but both sexes showed
similar changes in weight. The body weight loss was accom-
panied by the decreased feed intake. These reductions were
considered related to the exposure to the test substance.
Table 6 Histopathological assessment of the lung and nasal cavity tissues in male rats
Recovery group
Recovery period 2 Weeks 4 Weeks
Concentration (mg/m3) 0 0.8 4 20 0 0.8 4 20
Nasal cavity
Number of animals 5 5 5 5 5 5 5 5
Hyperplasia, transitional epithelium (0) (0) (2) (5) (0) (0) (0) (2)
Minimal 0 0 2 0 0 0 0 2
Mild 0 0 0 4 0 0 0 0
Moderate 0 0 0 1 0 0 0 0
Mean ± SD 0 0 0.40 ± 0.55 2.20 ± 0.45 0 0 0 0.40 ± 0.55
Hypertrophy/hyperplasia, mucous cells, respiratory epithelium (0) (4) (5) (5) (0) (0) (0) (5)
Minimal 0 4 2 0 0 0 0 4
Mild 0 0 3 2 0 0 0 1
Moderate 0 0 0 3 0 0 0 0
Mean ± SD 0 0.80 ± 0.45 1.60 ± 0.55 2.60 ± 0.55 0 0 0 1.20 ± 0.45
Metaplasia, mucous cells, transitional epithelium (0) (4) (4) (0) (0) (0) (0) (0)
Minimal 0 3 1 0 0 0 0 0
Mild 0 1 3 0 0 0 0 0
Mean ± SD 0 1.00 ± 0.71 1.40 ± 0.89 0 0 0 0 0
Infiltration, submucosa, transitional epithelium (0) (0) (0) (2) (0) (0) (0) (1)
Minimal 0 0 0 1 0 0 0 1
Mild 0 0 0 1 0 0 0 0
Mean ± SD 0 0 0 0.60 ± 0.89 0 0 0 0.20 ± 0.45
Infiltration, submucosa, respiratory epithelium (0) (0) (0) (1) (0) (0) (0) (0)
Mild 0 0 0 1 0 0 0 0
Mean ± SD 0 0 0 0.40 ± 0.89 0 0 0 0
Squamous metaplasia, transitional epithelium (0) (0) (0) (4) (0) (0) (0) (1)
Minimal 0 0 0 4 0 0 0 1
Mean ± SD 0 0 0 0.80 ± 0.45 0 0 0 0.20 ± 0.45
0: unremarkable = no presence of histopathologic lesion; 1: minimal = lesions involving< 10% of the tissue of each organ; 2: mild = lesions involving< 10–30% of
the tissue of each organ; 3: moderate = lesions involving< 30–50% of the tissue of each organ; 4: marked = lesions involving< 50–70% of the tissue of each organ;
5: severe = lesions involving> 70% of the tissue of each organ
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The hematological test results showed changes in the
RBC count, HCT level, HGB level, and MCHC in the
male T3 group rats. The results also showed changes in
the RBC count, and HCT and HGB levels in the male
T2 group rats and the HGB level in the male T1 group
rats. These changes are considered to be due to weight
loss with dehydration [27].
The changes in the MCV, reticulocyte count and ratio,
PLT count, APTT, and PT in the male T3 group rats;
the reticulocyte count and ratio, PLT count, and PT in
the male rats exposed to T2 group rats; the reticulocyte
count and ratio, APTT, and PT in the female T3 group
rats; and the PT in the female T2 group rats were ob-
served. These changes can be attributed to the reduction
in hematopoietic function due to the decrease in feed in-
take and the subsequent weight loss [28, 29]. The
changes in the number of lymphocytes observed in the
T3 group rats were inferred to be due to nutritional defi-
ciency or stress due to weight loss [30]. In addition,
there was no toxicological significance in the basophil
count of the male T2 and T3 group rats and in the
monocyte count of the female T3 group rats.
In the blood biochemical test, the increase in the ALT
activity in the male T3 group rats is considered to be re-
lated to liver atrophy observed in histopathological
examination [28] (Additional file 1: Table S5). On the
contrary, the changes in the ALP activity in the male T3
group rats and the TG level and CK activity in the male
T3 group rats were considered to be due to the decrease
in feed intake causing weight loss. In addition, the sig-
nificant increase in the K and Na levels observed in fe-
male rats is thought to be due to dehydration by
epithelial cell stimulation by BAC.
In the BALF analysis, the concentration of ROS/RNS,
IL-1β, IL-6, and MIP-2 decreased dose dependently at
the end of the exposure period, but did not show a
concentration-dependent change at 4 weeks of recovery.
In addition, the concentrations of TNF-α, IL-4, and
TGF-β did not show changes associated with test sub-
stance exposure. Although IL-6 is traditionally consid-
ered as proinflammatory cytokine, it is highly
polymorphic and its anti-inflammatory activity has been
reported [31]. In addition, a reduction in inflammatory
cells, decrease in chemokine and inflammatory cytokine
expression, and alteration in macrophage mobilization in
JP-8-induced dermatitis strongly suggest the role of anti-
inflammatory response, rather than inducing IL-6 in-
flammatory response. These changes in the expression
or function of these cytokines might modulate stimula-
tory sensitivity in human [32]. The concentration-
Fig. 6 Total cell counts from bronchoalveolar lavage fluid (BALF) and composition of cell population as a percentage of total cells after BAC
exposure (a-c). The values are expressed as mean ± SD (n = 5 males per group)
Choi et al. Particle and Fibre Toxicology            (2020) 17:5 Page 13 of 19
dependent decrease in the concentrations of ROS/RNS,
IL-1β, IL-6, and MIP-2 in this study was caused by the
stimulation of the test substance, and cytokines such as
IL-6, IL-1β, and MIP-2 are thought to function together.
In the measurement of organ weights, changes in
the weights of the brain, heart, lungs, liver, spleen,
and kidneys of the male and female T2 and T3
group rats, size reduction and atrophy of the liver
and spleen in the male and female T3 group rats
(Additional file 1: Table S5) were considered to be
due to weight loss [33, 34]. In the recovery group,
the body and organ weights of rats gradually
improved.
The autopsy results showed that the black lesions in
the lungs of male T3 group rats were consistent with the
hemoglobin crystallographic findings of the alveolar
muscle in the histopathological examination. The size
reduction observed in the thymus, testis, epididymis,
seminal vesicles, prostate, uterus, and vagina was con-
sistent with the atrophic findings in the macroscopic
examination. Furthermore, the squamous metaplasia of
the respiratory epithelium and transitional epithelium,
mucinous cell hypertrophy and proliferation of the re-
spiratory epithelium, mucinous cell metaplasia of the
transitional epithelium in the nasal cavities, and mucin-
ous cell hypertrophy and proliferation of terminal
Fig. 7 Concentrations of cytokines in bronchoalveolar lavage fluid (a-g). The values are expressed as mean ± SD (n = 5 males per group).
Significantly different from control by Dunn Rank Sum test: *p < 0.05, **p < 0.001
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bronchiole are considered adaptive changes after tissue
injury [35]. The atrophy of the thymus was considered
to be due to stress from weight loss [36].
In histopathological examination, changes in the re-
spiratory epithelium and transition epithelium of the nasal
cavity, atrophy of the erosive and olfactory epithelium
with necrosis, denaturation and regeneration of the re-
spiratory bronchial epithelium, hypertrophy of the smooth
muscle in the bronchial alveolar junction, and cell debris
indicated damage due to stimulation by the test substance.
Peripheral eosinophil infiltration in the lung is thought to
be an allergic reaction because it is associated with in-
creased eosinophil ratio and eosinophil count.
Histopathological findings in the nasal cavity and lungs
verified that BAC induced irritation in the nasal cavity and
the lungs, which were the main organs affected in the re-
spiratory system. ROS/RNS, IL-1β, IL-6, and MIP-2 levels
decreased in a BAC concentration-dependent manner, in-
dicating that BAC exposure caused oxidative damage. The
decrease in the level of IL-6, an anti-inflammatory agent,
led to a decrease in ROS/RNS, an indicator of oxidative
damage. At this time, IL-1β and MIP-2, together with IL-
6, are considered to be acting as cytokines. Therefore,
additional research is needed to clarify this hypothesis.
Inhaled substances may affect the respiratory system
at various levels according to various factors, such as the
characteristics of substances, environment, and host fac-
tors. The nasal cavity is important in inhalation toxicol-
ogy because nose is the first part of the respiratory tract
that contacts and filters airborne particles [37]. The mu-
cosa in the nasal cavity is the first tissue of defense
against inhaled particles in upper airway [38, 39]. In-
haled particles are trapped in mucus and removed to be
swallowed by the coordination with the movement of
ciliary epithelium [38, 39]. BAC has been shown to in-
hibit the nasal mucociliary activities via damaging the cili-
ated nasal epithelial cells [40, 41, 42]. BAC is a human
skin and severe eye irritant [43]. It is a suspected respira-
tory toxicant, immunotoxicant, gastrointestinal toxicant,
and neurotoxicant [44–46]. BAC for consumer use are di-
lute solutions. Concentrated solutions are toxic to
humans, causing corrosion/irritation to the skin and mu-
cosa, and death if taken internally in sufficient volumes.
Several studies have shown the nasal toxicity of BAC in
animals and humans. The administration of 0.05 and
0.10% (w/v) BAC solutions to the nasal cavity of rats
caused epithelial inflammation, desquamation, and edema
in the dorsal meatus and adjacent nasal septum [47].
BAC-containing nasal decongestant sprays induced or ag-
gravated nasal swelling and stuffiness in healthy volunteers
and patients with rhinitis compared with those of sprays
without BAC [48–50]. Recently, the adverse effects of
BAC through inhalation exposure and the target organ of
BAC toxicity can be shifted to the upper respiratory
organs rather than the deeper lower airway [51]. In this
study, more exposure-related effects were observed in the
upper airway. As mentioned above, BAC is thought to be
more exposed to the upper respiratory tract due to muco-
ciliary clearance and emergency airway response caused
by the irritation of BAC. In addition, NOAEL is consid-
ered to be less than 0.8mg/m3 because the effects associ-
ated with BAC exposure were also observed in the nasal
cavity of rats exposed to a concentration of mg/m3.
Thus, from these results, we calculated the BMD value
because the exposure criteria are required to protect the
health of workers handling BAC. The BMD recom-
mended by the Environmental Protection Agency should
be calculated to overcome the drawbacks of NOAEL,
which is dependent on exposure concentration. The
BMD calculation yielded the BMDL, the 95% lower con-
fidence of the dose corresponding to 10% reaction inci-
dence, and the lowest value was selected as the BMD
value. The toxicity data for dose response were body
weight, lung weight, RBC count, HCT level, Hb level,
MCHC, MCV, RETA, RET%, PLT count, LYMA, APTT,
PT, TG level, and ALT, ALP, and CK activities, and the
models were Exponential and Hill. The BMDL values
obtained were 0.10, 0.0031, 0.63, 1.53, 1, 37.5, 33.5, 0.55,
0.39, 0.89, 0.29, 0.12, 0.26, 0.86, 0.085, 0.082, and 0.208
mg/m3, respectively. Therefore, we chose 0.0031 mg/m3
as the BMD value, the dose corresponding to lung
weight-related dose-response, and the DNEL was
0.000062mg/m3, determined by applying an interspecies
factor of 2.5, intraspecies factor of 5, and exposure dur-
ation factor of 4 as default assessment factors [52].
Conclusions
BAC could be introduced to the occupational environ-
ment of the workers handling it, and it was necessary to
identify the hazard as a causative substance of the hu-
midifier disinfectant accident. Because biocides are
widely used, the risk of accidental exposure is high and
consequently, there is a need to curb the health prob-
lems due to such exposures in workers in various fields.
Therefore, this study was conducted to evaluate the ef-
fects of BAC inhalation exposure for 14 days using an in-
halation chamber system and a mist generator. Overall,
the study results confirmed that the main targets of re-
petitive systemic inhalation of BAC are the respiratory
system, including the nasal cavity and lungs. In particu-
lar, BAC was found to cause irritation in the nasal cavity
and lungs, which are located in a relatively upper pos-
ition than the deep lower airway of the respiratory sys-
tem, and the irritation was caused by oxidative damage;
it is thought that IL-6, IL-1β, and MIP-2 cytokines func-
tioned together. In addition, the parasympathetic nerve
responded to the animal’s defensive response to these ir-
ritations, resulting in clinical signs of nasal discharge,
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rale, and deep respiration. It is judged that the animals’
health is worsened as a result of weight loss due to re-
duced feed intake. These changes led to changes in
blood biochemistry and hematological parameters, which
gradually recovered during the recovery period. From
the results, the NOAEL was considered to be less than
0.8 mg/m3. Therefore, by applying the dose-response
data using a mathematical model, the BMD was calcu-
lated to be 0.0031 mg/m3. The DNEL value converted
from these BMD values to human exposure according to
information requirements and chemical safety assess-
ment guidelines was defined as 0.000062mg/m3.
Methods
Chemicals and animals
Benzalkonium chloride (concentration 50.5%) was pur-
chased from Samchun Chemicals (Pyeongtaek, Korea).
To generate the aerosol form of BAC in the whole-body
exposure chamber, BAC was diluted to 1–2% (v/v) with
microfiltration and by using UV-sterilized water.
Six-week-old Fischer 344 rats were supplied by Japan
SLC Inc. (Shizuoka, Japan) and were used in the experi-
ments after an 8-day acclimation period. The body
weight range of males at the start of exposure to BAC
after the acclimation period was 129.40–190.07 g and
that of females was 122.07–145.58 g. The rats were indi-
vidually housed in six-wire mesh cages (W 240mm × L
1200 mm×H 200mm) during the exposure period. The
environment conditions were as follows: temperature,
22 °C ± 3 °C; relative humidity, 30–70%; light/dark cycle,
12 h each; light intensity, 150–300 Lux; and air ventila-
tion, 10–15 times/h. The rats were fed pelleted food
(ENVIGO RMS Inc., Indianapolis, IN, USA) sterilized
using gamma rays and were provided filtered and steril-
ized tap water ad libitum. All animal experiments were
approved by the Institute Animal Care and Use Com-
mittee of Occupational Safety and Health Research Insti-
tute (AEC-200806230002).
Experimental design
Based on their body weight, the rats were randomly allo-
cated to five animals per test group, using PRISTIMA
7.1.0 software (Xybion Medical Systems Corporation,
Morris Plains, NJ, USA). The male and female rats were
divided into the following four main groups: a control
and three test groups; the test group rats were subjected
to whole body exposure to BAC for 14 days. In addition,
to assess the effects of cytokines on oxidative damage
and toxic reversibility, only male rats were provided the
recovery periods of 2 and 4 weeks, respectively. The ex-
perimental concentrations of BAC were selected based
on the results of our previous acute inhalation toxicity
study. In the acute inhalation toxicity study of BAC con-
ducted in accordance with OECD TG 436, bleeding
from the nasal cavity was observed in all the rats after
exposure to 50 mg/m3 BAC. Therefore, in this study, the
highest concentration of 20mg/m3 (T3 group), which is
expected to induce no mortality and repeated toxicity
upon repeated inhalation exposure, was set as the high
concentration of exposure, and 4 (T2 group) and 0.8 mg/
m3 (T1 group) were set as the medium and low concen-
trations, respectively, using a common ratio 5. In Korea,
when BAC is used as a humidifier disinfectant, the con-
centration is 1.869mg/m3 (product concentration 0.045%,
2.5 g of product is diluted in 500mL of water; the max-
imum spray volume of humidifier 500mL/h, 24-h use,
average volume of room 30.3m3, and winter air change
rate 0.2/h) [53]. Thus, the low concentration set in this
study was 0.43 times the actual environmental concentra-
tion. The control group was exposed to clean air passed
through high efficiency particulate air filters.
Exposure and monitoring
The prepared test substance was aerosolized using an
atomizer-type mist generator (NB-2 N; Sibata Co. Ltd.,
Japan). Diluted air obtained using the Aerosol Dilution
System was mixed with the generated aerosol and sup-
plied to the whole-body exposure chamber (1.4 m3). The
control group was supplied only clean air without the
test substance and the housing environment condition
was the same as that of the test groups.
To confirm the concentration of the test substance in
the chambers, samples of the test substance were collected
three times from the respirable area of the rats in the
chambers using a personal sample collector (Airchek® XR
5000 Sample Pump, SKC Inc., PA 15330, USA) connected
to a filter holder with a 25-mm micro glass fiber filter.
The actual concentrations in the chambers were deter-
mined using the gravimetric method to calculate the filter
weight measured before and after sampling. In addition,
the number of aerosol particles in the chamber was
checked using a Portable Aerosol Spectrometer (GRIMM
Aerosol Ainring Technik GmbH & Co. KG, Salzburg,
Germany) in real time during the generation of test sub-
stance. The mass median aerodynamic diameter (MMAD)
and geometric standard deviation (GSD) for each expos-
ure concentration were determined once during the ex-
posure period using a Cascade impactor (MiniMOUDI
Impactor, MSP Co. Ltd., Minnesota 55,126, USA).
Observation and measurements
Clinical signs were observed daily during the experiment and
the body weight of the rats was measured on the day of ex-
posure, twice a week during the exposure period, once a
week during the recovery period, and on the day of autopsy.
Feed intake by the rats was measured once a week during
the exposure and recovery periods. At the time of autopsy,
blood was collected from all the rats under the influence of
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isoflurane inhalation anesthesia. The rats were then eutha-
nised by bleeding. The external surface, all orifices, and the
organs of the abdominal, thoracic, and cranial cavities were
examined. Subsequently, the brain, liver, heart, lungs, spleen,
and kidneys, were dissected and weighed. Bronchoalveolar
lavage fluid (BALF) was collected from the right lobe of the
lung using phosphate buffered saline (PBS) and the left lobe
was weighed and fixed in 10% neutral buffered formalin.
Hematological and blood biochemical analyses
From the anaesthetized rats, 0.5 mL of blood collected
from the abdominal artery was added to a blood collection
tube containing an anticoagulant (EDTA-2 K) and ana-
lyzed using a hematology analyzer (ADVIA 2120i, Sie-
mens, Munich, Germany). Plasma was separated from the
collected blood by placing 1ml in a tube containing 3.2%
sodium citrate and centrifuging at 450 g for 10min. A co-
agulation analyzer (ACL ELITE, Werfen Company, Bed-
ford, MA, USA) was used in the blood coagulation test.
The following parameters were analyzed: the total count
of white blood cell (WBC) count, absolute and relative
counts of differential WBC, red blood cell (RBC) count,
absolute and relative counts of reticulocytes, hemoglobin
(Hb) level, hematocrit (HCT) level, mean corpuscular vol-
ume (MCV), mean corpuscular hemoglobin (MCH) level,
mean corpuscular hemoglobin concentration (MCHC),
platelet (PLT) count, prothrombin time (PT), and acti-
vated partial thromboplastin time (APTT).
For the blood biochemistry test, the blood samples ex-
cept those used for the hematological analyses were
added to a tube without anticoagulant, and the samples
were placed at 20 °C for 90 min or longer. The samples
were then centrifuged at 450 g for 10 min to separate the
serum. The following parameters were measured using a
blood biochemical analyzer (TBA-120FR; Toshiba Co.,
Tochigi, Japan): the level of glucose, blood urea nitrogen,
total protein, albumin, creatinine, total cholesterol, tri-
glyceride (TG), total bilirubin, potassium (K), calcium
(Ca), chloride (Cl), inorganic P, and Na; activity of γ-
glutamyl transferase, lactate dehydrogenase, creatinine
phosphokinase (CK), aspartate aminotransferase, alanine
aminotransferase (ALT), and alkaline phosphatase
(ALP); and the ratio of albumin-to-globulin.
Histopathological analysis
The extracted organs were fixed in 10% neutral-
buffered formalin and embedded in paraffin. The em-
bedded tissue blocks were cut into 3-μm thick sec-
tions and stained with hematoxylin and eosin. The
stained sections were examined using a light micro-
scope (Axio Scope A1, 07745 Jena, Germany), and the
nomenclature of histopathological assessments is de-
scribed according to reference 11.
Bronchoalveolar lavage fluid analysis and cytokines
The bronchoalveolar lavage fluid was analyzed only in male
rats 2 weeks after exposure and 4weeks of recovery. To ob-
tain BALF, the upper end of the trachea was cut and a poly-
propylene tube attached to a syringe was inserted, and then
the trachea was washed three times with 4mL of PBS. The
collected BALF was centrifuged at 450 g for 10min and the
supernatant was stored at − 80 °C. The cell pellet was re-
suspended in fresh PBS and the total immune cell count was
determined using a hematology analyzer (ADVIA 2120i).
The re-suspended cell pellet was centrifuged at 270 g for 10
min using a cytospin centrifuge (Cellspin; Hanil, Gimpo,
Korea) and stained using Diff-Quick staining solution. The
differential cell counts were determined using a light micro-
scope at 100× magnification.
Cytokine analysis
The supernatant separated from the BALF was thawed at
around 20 °C just before the cytokine analysis. A commer-
cially available cytokine multi-magnetic bead array kit (R &
amp; D Systems, Minneapolis, MN 55413) was used to
analyze the concentration of interleukin (IL)-1β, IL-6, IL-4,
tumor necrosis factor α (TNF-α), and macrophage inflam-
matory protein 2-alpha (MIP-2) in the BALF. The Magnetic
Bead Single Plex Kit (MILLIPLEX MAP; Merck Millipore,
Darmstadt, Germany) was used to measure the concentra-
tion of transforming growth factor β (TGF-β). ROS/RNS
was analyzed using an OxiSelect™ In Vitro ROS/RNS Assay
Kit (Catalog No. STA-347; Cell Biolab, Inc., USA) and Var-
ioskan Flash Reader (Thermo Fisher Scientific, Finland). The
assays were performed per the manufacturers’ instructions.
The median fluorescence intensity (MFI) of the samples was
measured using a Luminex 100 instrument (Luminex, Aus-
tin, TX, USA) and a standard curve was obtained using Mas-
terPlex software (MasterPlex QT 2010; Miraibio, Hitachi,
CA, USA). The cytokine concentration was calculated using
the standard curve.
Statistical analysis
The data are presented as mean and standard deviation.
The data were statistically analyzed using PRISTIMA ver-
sion 7.1.0 (Xybion Medical Systems Corporation, Morris
Plains, NJ, USA). Levene test was performed to determine
the homogeneity of variance. When the variance was
homogeneous, the one-way analysis of variance was per-
formed, and statistical differences between the control and
test groups were analyzed using Dunnett’s test. When the
variance was heterogeneous, Kruskal-Wallis test was per-
formed, and statistical differences between the control and
test groups were analyzed using Dunn’s rank sum test(*p <
0.05, **p < 0.01). In addition, the benchmark dose (BMD)
was calculated using PROAST software version 65.2 pro-
vided (www.proast.nl) by the Dutch National Institute for
Public Health and the Environment (RIVM).
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